These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38583247)
1. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy. Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247 [TBL] [Abstract][Full Text] [Related]
2. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583 [TBL] [Abstract][Full Text] [Related]
4. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway. Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753 [TBL] [Abstract][Full Text] [Related]
5. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes. Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex. Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805 [TBL] [Abstract][Full Text] [Related]
7. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
8. Novel gold-based complex GC7 suppresses cancer cell proliferation via impacting energy metabolism mediated by mitochondria. Cui Q; Ding W; Luo B; Lu W; Huang P; Wen S Bioorg Med Chem; 2024 Oct; 112():117897. PubMed ID: 39216383 [TBL] [Abstract][Full Text] [Related]
9. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system. Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127 [TBL] [Abstract][Full Text] [Related]
10. Iridium(III) complexes conjugated with naproxen exhibit potent anti-tumor activities by inducing mitochondrial damage, modulating inflammation, and enhancing immunity. Xie K; Lu XY; Zhu H; Zhu LY; Li RT; Ye RR Dalton Trans; 2024 May; 53(20):8772-8780. PubMed ID: 38712840 [TBL] [Abstract][Full Text] [Related]
11. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics. Laws K; Eskandari A; Lu C; Suntharalingam K Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298 [TBL] [Abstract][Full Text] [Related]
12. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo. He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561 [TBL] [Abstract][Full Text] [Related]
13. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex. Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592 [TBL] [Abstract][Full Text] [Related]
14. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis. Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells. Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128 [TBL] [Abstract][Full Text] [Related]
16. Anticancer Ir Wu XW; Zheng Y; Wang FX; Cao JJ; Zhang H; Zhang DY; Tan CP; Ji LN; Mao ZW Chemistry; 2019 May; 25(28):7012-7022. PubMed ID: 30913329 [TBL] [Abstract][Full Text] [Related]
17. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules. Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200 [TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo of Triphenylamine-Appended Fluorescent Half-Sandwich Iridium(III) Thiosemicarbazones Antitumor Complexes. Shao M; Yao M; Liu X; Gao C; Liu W; Guo J; Zong J; Sun X; Liu Z Inorg Chem; 2021 Nov; 60(22):17063-17073. PubMed ID: 34709784 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria. Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986 [TBL] [Abstract][Full Text] [Related]
20. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells. Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]